Advertise on podcast: The BSH Guidelines Official Podcast

During this podcast, Dr Richard Buka and Prof Deepa Arachchillage discuss the BSH Position Paper ‘Use of andexanet alfa: A British Society for Haematology position statement', published in April 2026.

Dr Will Lester and Dr Ian Jennings discuss the Reporting haemostasis assays in IU/dL—A recommendation for harmonisation (BSH H&T Task Force / UK NEQAS / UK HCDO) paper, published in July 2025.

During this podcast, Matthew Hazell and Lynne Porter discuss the guideline for the estimation of fetomaternal haemorrhage, published in 2026.

During this podcast, Anna Godfrey discusses the Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations Guideline, published in 2025.

During this podcast, Piers Patten and Renata Walewska discuss the Guideline for the treatment of chronic lymphocytic leukaemia, published in 2025.

During this podcast, Dr Austin Kulasekararaj and Dr Lugain Abdalla discuss the Guidelines for the diagnosis and management of adult aplastic anaemia, published in 2024.

In this episode, Dr Charles Percy discusses the joint British Society for Haematology and United Kingdom Haemophilia Centre Doctors' Organisation Guideline on 'Laboratory investigation and clinical management of acquired coagulation factor inhibitors', published in 2025.

Dr Tracey Chan and Dr Dima El-Sharkawi discuss the Updated guidelines for the diagnosis and management of tumour lysis syndrome in adults and children, published in 2025.

Dr Matthew Wilson, Dr Sridhar Chaganti and Dr Wendy Osborne discuss the Clinical management of bispecific antibody therapy for lymphoma Good Practice Paper, published in 2025.

Dr Eyre is a consultant haematologist specialising in lymphoid malignancies in Oxford.  He has completed an MD Doctorate Thesis in 2017.  He is an investigator on several national lymphoid trials and has published over 170 peer-review articles on lymphoma and CLL.  He is the chair of the low-grade lymphoma clinical trial research group and a core member several lymphoma study groups.  He is a member of the BSH guideline writing groups for various lymphoma subtypes and the lead author for the new ESMO Lymphoma guidelines.  ​He is also an Associate Editor at the British Journal of Haematology.

Podcast recording by James Griffin on the Guideline: Apheresis procedures for the treatment of patients and for the collection of cellular therapy products.

Dr Deepa J. Arachchillage and Dr Jenny Tam present a review of the Guidelines on the investigation and management of antiphospholipid syndrome. Published: 04 August 2025

Dr Matthew Wilson and Dr Kate Cwynarski discuss the Central nervous system prophylaxis in large B-cell lymphoma Good Practice Paper, published in 2024.

Professor Christopher Fox, Dr Sridhar Chaganti and Dr Bernard Maybury discuss the Management of relapsed or refractory large B-cell lymphoma Guideline, published in 2025.